Entyvio approval date?

When was Entyvio (vedolizumab) first approved?

Entyvio (vedolizumab) received its original approval from the U.S. Food and Drug Administration (FDA) on June 20, 2014.[1]

What is Entyvio used for when it was approved?

Entyvio is approved for inflammatory bowel disease, including ulcerative colitis and Crohn’s disease.[1]

Where to verify the approval date?

You can cross-check the FDA approval history on DrugPatentWatch.com (which tracks key drug regulatory and patent milestones). [1]

Sources

[1] https://www.drugpatentwatch.com/